Search
for
Sort by
Research 451–480 of 1000+
- Astilbin Activates the Reactive Oxidative Species/PPARγ Pathway to Suppress Effector CD4+ T Cell Activities via Direct Binding With Cytochrome P450 1B1
- Altered hair root gene expression profiles highlight calcium signaling and lipid metabolism pathways to be associated with curly hair initiation and maintenance in Mangalitza pigs
- Targeting Wnt/β-catenin signaling and its interplay with TGF-β and Notch signaling pathways for the treatment of chronic wounds
- Small Molecule Agents Against Alopecia: Potential Targets and Related Pathways
- Comparative Transcriptome Analysis of the Regenerating Zebrafish Telencephalon Unravels a Resource With Key Pathways During Two Early Stages and Activation of Wnt/β-Catenin Signaling at the Early Wound Healing Stage
- Depletion of <i>Gsdma1/2/3</i> alleviates PMA-induced epidermal hyperplasia by inhibiting the EGFR–Stat3/Akt pathway
- Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- A review of Janus kinase inhibitor use in scarring alopecia
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Baricitinib in the Management of Coexisting Alopecia Areata and Atopic Dermatitis: A Case Report
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients.
- Deucravacitinib in dermatology: current indication and existing off-label data
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- S3886 Concurrent Management of Crohn's Ileitis and Alopecia Universalis With Upadacitinib
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Exploring novel management options for alopecia areata
- Real-world evidence in alopecia areata treatment: A narrative review
- The Current State of Patient Adherence to Lab Monitoring Guidelines for Janus Kinase Inhibitors in Patients with Alopecia Areata.
- Review of efficacy of baricitinib in the treatment of alopecia areata
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Alopecia Areata: An Updated Review for 2023
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia
- Personalized Medicine in the Field of Inflammatory Skin Disorders
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs